Latest News

MS Brain Health Seminar: A Review

October 24, 2024 | Education, Event, Progressive, Research, Webinar

On 12th July 2024 Multiple Sclerosis New Zealand (MSNZ) co-hosted our MS Brain Health seminar in Auckland with the NZ MS Research Trust and MS Auckland. Thank you to all attendees that came to hear from our special guest speaker, […]


Media Release: New report calls for major change to Pharmac’s funding model

October 15, 2024 | Media, News, Press Release, Progressive

Pharmac’s decision-making process for funding drugs in Aotearoa New Zealand is in need of a major overhaul – according to a new independent report. The Milne Report, commissioned by Multiple Sclerosis New Zealand (MSNZ), says its time Pharmac based its […]


Update – Ocrelizumab for Primary Progressive MS in Canterbury

May 29, 2024 | Life with MS, News, Progressive, Treatments

On Wednesday 15 May, Multiple Sclerosis NZ raised how critical workforce shortages are impacting patients with Primary Progressive MS (PPMS) access to time sensitive disease modifying therapies. A business case prepared by clinical specialists had been under review for five […]


Press Release: Access to Life-Changing MS Drug “snatched away” Due to Staff Shortages

May 15, 2024 | Advocacy, Funding, Life with MS, Media, News, Press Release, Treatments

A celebrated Pharmac decision late last year to fund a vital drug for many Multiple Sclerosis patients has fallen flat – with dozens being turned away for treatment due to severely stretched resources across a number of services. Multiple Sclerosis […]


Ocrevus for PPMS – Your Questions Answered

September 14, 2023 | Treatments

  Here’s what you need to know about Ocrevus (ocrelizumab) for Primary Progressive MS. Download PDF copy here: PPMS Ocrevus FAQ – 13 September 2023.   What medicines are available to treat Primary Progressive Multiple Sclerosis (PPMS)?  There is only […]